These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8335575)

  • 21. Protamine-induced pulmonary venoconstriction in heparinized pigs.
    Hakim TS; Picone A; Oleary CE; Camporesi EM
    Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
    Tesfamariam B
    J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia.
    Slotman GJ; Yellin SA; Handy JR; Hulstyn M; Husain SE; Gann DS
    Surgery; 1986 Aug; 100(2):214-21. PubMed ID: 3526603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
    Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
    Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen free radicals in ischemic acute renal failure in the rat.
    Paller MS; Hoidal JR; Ferris TF
    J Clin Invest; 1984 Oct; 74(4):1156-64. PubMed ID: 6434591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of protamine does not attenuate circulatory changes caused by protamine reversal of heparin in dogs.
    Mizutani T; Takahashi S; Kihara S; Toyooka H
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):346-51. PubMed ID: 11426367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.
    Holm P; Liska J; Clozel M; Franco-Cereceda A
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):890-7. PubMed ID: 8873714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia and reoxygenation of the lung tissues induced mRNA expressions of superoxide dismutase and catalase and interventions from different antioxidants.
    Shen CY; Lee JF; Su CL; Wang D; Chen CF
    Transplant Proc; 2008 Sep; 40(7):2182-4. PubMed ID: 18790186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-alpha alters pulmonary vasoreactivity via neutrophil-derived oxidants.
    Ferro TJ; Hocking DC; Johnson A
    Am J Physiol; 1993 Nov; 265(5 Pt 1):L462-71. PubMed ID: 8238533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endothelin-1 and thromboxane A2 in the pulmonary hypertension induced by heparin-protamine interaction in anesthetized dogs.
    Freitas CF; Faro R; Dragosavac D; Clozel M; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):106-12. PubMed ID: 14668575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-2-induced lung injury is mediated by oxygen free radicals.
    Klausner JM; Paterson IS; Goldman G; Kobzik L; Lelcuk S; Skornick Y; Eberlein T; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1991 Feb; 109(2):169-75. PubMed ID: 1899491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of the leukocyte-endothelial cell interaction in collecting venules of skeletal muscle by protamine.
    Habazettl H; Martinek V; Vollmar B; Conzen P
    J Thorac Cardiovasc Surg; 1997 Apr; 113(4):784-91. PubMed ID: 9104989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
    Yoshioka M; Wakamatsu M; Kuro M; Okumura F
    Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions.
    Kreil E; Montalescot G; Greene E; Fitzgibbon C; Robinson D; Chenoweth D; Zapol WM
    J Appl Physiol (1985); 1989 Oct; 67(4):1463-71. PubMed ID: 2793750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist.
    Aïssa J; Nathan N; Arnoux B; Benveniste J
    Eur J Pharmacol; 1996 Apr; 302(1-3):123-8. PubMed ID: 8791000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung.
    Degges RD; Foster ME; Dang AQ; Read RC
    Am J Surg; 1987 Dec; 154(6):696-9. PubMed ID: 3425821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin reversal by protamine in humans--complement, prostaglandins, blood cells, and hemodynamics.
    Hobbhahn J; Conzen PF; Habazettl H; Gutmann R; Kellermann W; Peter K
    J Appl Physiol (1985); 1991 Oct; 71(4):1415-21. PubMed ID: 1757364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.